In a third of patients with ALL and the majority of those with CML, the breakpoint occurs within a 5.8 kb region spanning BCR exons 12–16 (exons b1–b5), known as the major bcr (M-bcr). This evidence concerns the gene BCR and acute lymphoblastic leukemia.